Pressmeddelande - 24 Augusti 2011 07:01

Massive Demand – Extended IPO Period

The demand from patient organizations and relatives to get Brighter One™ demonstrated has by far surpassed Brighter’s expectations. Since the company wishes to spread the information about the company and Brighter One^TM as broadly as possibly, the board decided to extend the issuing period until September 26.

“The response we have received is fantastic and an extension serves a dual purpose. On the one hand, we get to meet more interested investors, but above all, we get a splendid chance to demonstrate Brighter One for those who will actually use it” says Truls Sjöstedt, CEO.

During the period until September 26, the company will give a large number of presentations, of which various will be open to the public. If you want to get updated on occasions in your proximity, send in your contact details and your place of residence to: presentation@brightercompany.com.

About Brighter AB (publ)

Brighter develops and commercializes innovative solutions for diabetes self-cafe. It is a STING Alumni company. Financing has come from state and institutional investors such as ALMI, Innovationsbron, KAS Innovationsfond (an activity within the Karl-Adam Bonnier foundation) as well as from private investors.

During the period August 15 to September 26, there is a unique opportunity to issue shares in Brighter. After the introduction issuing, Brighter will be listed at AktieTorget. For more information: www.BrighterCompany.com.

Brighter's all-in-one solution: Brighter One TM Full Video

Contact Information

http://www.BrighterCompany.com/

http://www.BrighterCompany.com/video

http://www.facebook.com/brightercompany

http://twitter.com/Brighter_AB

Phone: +46 8 55 00 88 20

Fax: +46 8 55 00 88 30

Truls Sjöstedt, VD på Brighter AB (publ)

Phone: +46 709 73 46 00

E-mail: truls.sjostedt@brightercompany.com

Ämnen

Företagande

Kategorier

extended
massiv demand
listning
nyemission
diabetes
aktietorget
brighter
ipo

Brighter's all-in-one solution: Brighter One TM Full Video

Relaterat innehåll

20 Augusti 2011 08:01

Brighter Has Launched Its Initial Public Offering Period

Brighter AB (publ) has launched its Initial Public Offering period at AktieTorget as promised. The company has developed and patented the world’s first all-in-one self-care device for diabetics that does not need to be attached to the body. Now, the public is offered a unique opportunity to take part in Brighter’s future growth through the IPO.

21 Augusti 2011 08:01

Brighter Sheds Light on the Darkness of the Stock Markets

In the middle of one of the darkest periods on the stock markets, medtech company Brighter AB (publ) invites to its IPO at AktieTorget with the purpose to attract 8.5 MSEK. With the main patent approved a year earlier than planned, Brighter leaves the development period and goes on to commercializing the product portfolio Brighter One TM, an attractive world news with great global potential.

23 Augusti 2011 09:59

Högtryck på efterfrågan - förlängd teckningstid

Då möjlighet att teckna sig för aktier och få presentationer av Brighter One™ har vida överstigit förväntningarna väljer Brighters styrelse att utöka teckningstiden till och med den 26:e september.

16 September 2011 12:41

Global Attention Calls for International Investment Information

As a result of its patented diabetes device having reached more widespread attention earlier than anticipated, Brighter is releasing a summary of the company’s investment information in English. This information is to accommodate international investors interested in the Swedish medtech company based in Stockholm.

5 September 2011 23:02

Brighter Presents at Medtech Investment Day Scandinavia in Stockholm

During an all day event, organized by the Nordic medtech industry organizations, leading institutional and private investors are brought together with carefully selected companies of the future.